Literature DB >> 3470009

Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells.

K I Kariya, Y Kawahara, T Tsuda, H Fukuzaki, Y Takai.   

Abstract

In cultured rabbit aortic vascular smooth muscle cells (VSMC), protein kinase C-activating phorbol esters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and phorbol-12,13-dibutyrate (PDBu) stimulated DNA synthesis in the presence of 10% cell-free plasma-derived serum. This stimulation was half that shown by PDGF. 4 alpha-Phorbol-12,13-didecanoate, known to be inactive for protein kinase C, was without effect in stimulating DNA synthesis. Prolonged treatment of the cells with PDBu led to a marked decrease in protein kinase C. In the pDBu-treated cells, the TPA-stimulated DNA synthesis was completely abolished whereas the PDGF-stimulated DNA synthesis was decreased to about half that in the control cells. These results suggest that protein kinase C is involved in PDGF-stimulated proliferation of VSMC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470009     DOI: 10.1016/0021-9150(87)90128-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Protein kinase C does not regulate diacylglycerol metabolism in aortic smooth muscle cells.

Authors:  M Chuang; K R Dell; D L Severson
Journal:  Mol Cell Biochem       Date:  1990-07-17       Impact factor: 3.396

3.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

Authors:  G H Gibbons; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2.

Authors:  X Li; V Van Putten; F Zarinetchi; M E Nicks; S Thaler; L E Heasley; R A Nemenoff
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

5.  Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C.

Authors:  A C Newby; K Lim; M A Evans; N P Brindle; R F Booth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Characterization of bovine aortic protein kinase C with histone and platelet protein P47 as substrates.

Authors:  K R Dell; M P Walsh; D L Severson
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

Review 7.  Therapeutic potential of protein kinase C inhibitors.

Authors:  D Bradshaw; C H Hill; J S Nixon; S E Wilkinson
Journal:  Agents Actions       Date:  1993-01

8.  Vasopressin stimulates phospholipase D activity against phosphatidylcholine in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; H T Cao; H Chabbott
Journal:  Lipids       Date:  1990-11       Impact factor: 1.880

9.  Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells.

Authors:  J W Assender; K M Southgate; M B Hallett; A C Newby
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

10.  Effect of protein kinase C activation and inhibition on rat hepatic stellate cell activation.

Authors:  Grant A Ramm; Lin Li; Robert S Britton; Rosemary O'Neill; Bruce R Bacon
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.